712 related articles for article (PubMed ID: 29929399)
41. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
43. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.
Baratta F; Pastori D; Angelico F; Balla A; Paganini AM; Cocomello N; Ferro D; Violi F; Sanyal AJ; Del Ben M
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2324-2331.e4. PubMed ID: 31887443
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation.
Pastori D; Sciacqua A; Marcucci R; Farcomeni A; Perticone F; Del Ben M; Angelico F; Baratta F; Pignatelli P; Violi F;
Mayo Clin Proc; 2020 Mar; 95(3):513-520. PubMed ID: 31753536
[TBL] [Abstract][Full Text] [Related]
45. Doppler Tissue Evaluation of Atrial Conduction Properties in Patients With Non-alcoholic Fatty-liver Disease.
Ozveren O; Izgi C; Eroglu E; Simsek MA; Turer A; Kucukdurmaz Z; Cinar V; Degertekin M
Ultrason Imaging; 2016 May; 38(3):225-35. PubMed ID: 26157039
[TBL] [Abstract][Full Text] [Related]
46. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.
Møller S; Kimer N; Kronborg T; Grandt J; Hove JD; Barløse M; Gluud LL
Semin Liver Dis; 2021 Aug; 41(3):235-247. PubMed ID: 33992031
[TBL] [Abstract][Full Text] [Related]
47. Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation.
Donnellan E; Cotter TG; Wazni OM; Elshazly MB; Kochar A; Wilner B; Patel D; Kanj M; Hussein A; Baranowski B; Cantillon D; Griffin B; Jaber W; Saliba WI
JACC Clin Electrophysiol; 2020 Oct; 6(10):1278-1287. PubMed ID: 33092755
[TBL] [Abstract][Full Text] [Related]
48. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.
Kwok R; Choi KC; Wong GL; Zhang Y; Chan HL; Luk AO; Shu SS; Chan AW; Yeung MW; Chan JC; Kong AP; Wong VW
Gut; 2016 Aug; 65(8):1359-68. PubMed ID: 25873639
[TBL] [Abstract][Full Text] [Related]
49. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
[TBL] [Abstract][Full Text] [Related]
50. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics.
Younossi ZM; Henry L; Isaacs S; Cusi K
Endocr Pract; 2023 Nov; 29(11):912-918. PubMed ID: 37406857
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
[TBL] [Abstract][Full Text] [Related]
53. Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis.
Jaiswal V; Ang SP; Huang H; Momi NK; Hameed M; Naz S; Batra N; Ishak A; Doshi N; Gera A; Sharath M; Waleed MS; Raj N; Aguilera Alvarez VH
J Investig Med; 2023 Aug; 71(6):591-602. PubMed ID: 37002665
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
[TBL] [Abstract][Full Text] [Related]
55. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
[TBL] [Abstract][Full Text] [Related]
56. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
[TBL] [Abstract][Full Text] [Related]
57. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.
Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R
Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
59. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
[TBL] [Abstract][Full Text] [Related]
60. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions.
Li H; Hu B; Wei L; Zhou L; Zhang L; Lin Y; Qin B; Dai Y; Lu Z
Eur J Neurol; 2018 Mar; 25(3):577-e34. PubMed ID: 29281159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]